淡江大學機構典藏:Item 987654321/41264
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 58649/92364 (63%)
Visitors : 571421      Online Users : 76
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library & TKU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://tkuir.lib.tku.edu.tw:8080/dspace/handle/987654321/41264


    Title: Change of plasma transforming growth factor-β1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy
    Authors: Chen, Hong-wen;張玉坤;Chang, Yue-cune;Lai, Yuen-liang;Chen, Yu-jen;Huang, Ming-jer;Leu, Yi-shing;Fu, Ying-kai;Wang, Ling-wei;Hwang, Jeng-jong
    Contributors: 淡江大學數學學系
    Keywords: transforming growth factor-β1 (TGF-β1);nasopharyngeal carcinoma;concurrent chemo-radiotherapy
    transforming growth factor-β1 (TGF-β1);nasopharyngeal carcinoma;concurrent chemo-radiotherapy
    Date: 2005-08-01
    Issue Date: 2010-01-28 07:07:54 (UTC+8)
    Publisher: Oxford University Press
    Abstract: Objective: Our aim was to study the correlation between plasma transforming growth factor (TGF)-β1 level and radiation-induced mucositis and dermatitis in nasopharyngeal carcinoma (NPC) patients.

    Methods: Blood samples obtained from patients treated with concurrent chemo-radiotherapy (CCRT) were divided into two groups according to the pre-treatment plasma TGF-β1 level (≥7.5 ng/ml as group 1 and <7.5 ng/ml as group 2). Enzyme-linked immunosorbent assay (ELISA) was used for the measurement of the TGF-β1 level. Radiation toxicity was evaluated according to Radiation Treatment Oncology Group criteria. Data were analyzed by the generalized estimation equation method.

    Results: TGF-β1 levels of group 1 patients were decreased significantly (P = 0.002) at the end of the treatment. The rate of decrease was 0.12 ng/ml per fraction (P = 0.02). The average TGF-β1 level in patients who suffered acute radiation morbidity (grade ≥2) was significantly higher (P = 0.0057) than that of those who suffered less (grade <2).

    Conclusion: A lower pre-treatment plasma TGF-β1 level and the grade of radiation toxicity both appeared to contribute to the elevated plasma TGF-β1 after CCRT.
    Relation: Japanese Journal of Clinical Oncology 35(8), pp. 427-432
    DOI: 10.1093/jjco/hyi126
    Appears in Collections:[Graduate Institute & Department of Mathematics] Journal Article

    Files in This Item:

    File Description SizeFormat
    0KbUnknown352View/Open
    Change of plasma transforming growth factor-β1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy.pdf129KbAdobe PDF0View/Open
    index.html0KbHTML87View/Open

    All items in 機構典藏 are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library & TKU Library IR teams. Copyright ©   - Feedback